Alnylam Pharmaceuticals
ALNY
#618
Rank
$32.55 B
Marketcap
$251.56
Share price
3.69%
Change (1 day)
75.05%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company